JSA/WAO Joint Congress 2020

Session information

Poster Session

Internal Medicine

[PE32] Poster Session 32
Treatment for adult asthma 1

Hyeon-Jong Yang1, Nam-Eun Kim2, Sanghun Lee3, Sungho Won1,4,5 (1.Department of Pediatrics, Soonchunhyang University Seoul Hospital, Republic of Korea, 2.Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Republic of Korea, 3.Department of Medical Consilience, Graduate School, Dankook University, Republic of Korea, 4.Interdisciplinary Program of Bioinformatics, Seoul National University, Republic of Korea, 5.Institute of Health and Environment, Seoul National University, Republic of Korea)

Yu Nakanishi1, Hiroshi Iwamoto1, Satoshi Nakao1, Naoko Higaki1, Kakuhiro Yamaguchi1, Shinjiro Sakamoto1, Yasushi Horimasu1, Takeshi Masuda1, Naoko Matsumoto2, Taku Nakashima1, Shintaro Miyamoto1, Yojiro Onari3, Kazunori Fujitaka1, Yoshinori Haruta4, Hironobu Hamada1, Soichiro Hozawa5, Noboru Hattori1 (1.Department of Respiratory Internal Medicine, Hiroshima University Hospital, Japan, 2.Department of Respiratory Internal Medicine, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Japan, 3.Department of Respiratory Internal Medicine, Hiroshima Mazda Hospital, Japan, 4.Haruta Respiratory Clinic, Japan, 5.Hiroshima Allergy & Respiratory Clinic, Japan)

Reiko Ito1, Kazuto Nakagawa2, Fujio Koeda3, Yasuhiro Gon1 (1.Department of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Japan, 2.Department of Conceptual Design, Nihon University College of Industrial Technology, Japan, 3.Department of Design, Nihon University College of Art, Japan)

Sumiko Abe1, Jun Ito1, Yuuki Sandhu1, Takayasu Watanabe1, Takayasu Nishimaki1, Yukari Oyama1, Shoko Ueda1, Hitoshi Sasano1, Yuki Tanabe1, Tomohito Takeshige1, Sonoko Harada2, Ryo Atsuta1, Norihiro Harada1, Kazuhisa Takahashi1 (1.Department of Respiratory, Juntendo Hospital, Japan, 2.Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Japan)

Yasuhiro Tomita1,2, Yuma Fukutomi2, Mari Irie3, Kazuhiro Azekawa4, Yoichi Nakamura5, Chiharu Okada6, Terufumi Shimoda7, Miku Kuriki1, Katsuyuki Kojima1, Masami Taniguchi2 (1.Respiratory Medicine, Tokai Central Hospital, Japan, 2.Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan, 3.Nihon Medical Insurance Institute Ltd., Japan, 4.MHI Co., Ltd., Japan, 5.Medical Center for Allergic and Immune Diseases, Yokohama City Minato Red Cross Hospital, Japan, 6.Headquarters, National Hospital Organization, Japan, 7.Clinical Research Center, National Hospital Organization Fukuoka Hospital, Japan)

Yoichi Nakamura1, Soichiro Hozawa2, Hironori Sagara3, Hiroyuki Ohbayashi4, Andrew Fowler5, Laurie Lee6, Jodie Crawford5, Jun Tamaoki7 (1.Medical Center for Allergic and Immune Diseases Yokohama City Minato Red Cross Hospital, Japan, 2.Hiroshima Allergy and Respiratory Clinic, Japan, 3.Showa University School of Medicine, Japan, 4.Tohno Chuo Clinic, Japan, 5.GSK, UK, 6.GSK, USA, 7.GSK, Japan)